Bimekizumab in Chinese patients with active radiographic axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE 2 study.

Research paper from Europe PMC. Evidence status: source reported.

Published

2026-10-29

Source reference

MED:42952004

DOI

10.1097/cm9.0000000000004237

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Gu J, Lu L, Wang Q, Cheng Y, Xu S, Zhao Y, Zhu Q, Zhu X, Baraliakos X, Brown MA, Deodhar A, Wei JC, Marten A, Oortgiesen M, Vaux T, Xu H. · Chin Med J (Engl) · im; journal article · Found via: Genomics England

Source: https://europepmc.org/article/MED/42952004. Captured 2026-10-29.

Limitations: Discovered through a Europe PMC keyword search for Genomics England. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.